Cocrystal Pharma, Inc. (COCP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cocrystal Pharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.25x | -1.17x | -0.92x | -0.41x | -4.23x | -8.11x |
| P/B Ratio | 1.75x | 2.16x | 0.63x | 0.40x | 0.77x | 1.49x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 38.87x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -199.6% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -476.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -479.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -468.2% |
| Liquidity | ||||||
| Current Ratio | 3.68x | 4.77x | 8.92x | 33.04x | 38.40x | 25.05x |
| Quick Ratio | 3.68x | 4.77x | 8.92x | 33.04x | 38.40x | 25.05x |
| Leverage | ||||||
| Debt/Equity | 0.24x | 0.19x | 0.07x | 0.01x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..